speb/financial-data huggingface dataset:
GUF.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
GUF.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 160545.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 126478.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 0.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 7537022.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 126107.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 126107.00
GUF.V cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 126107.00
GUF.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -881677.00
GUF.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -72277.00
GUF.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 919516.00
GUF.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 262772.00
GUF.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 172270.00
GUF.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: 24783.00
GUF.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 459825.00
GUF.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 24783.00
GUF.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -34438.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 7537022.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 21942293.00
GUF.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 448524.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 597736.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2519673.00
GUF.V cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 40000.00
GUF.V cash_flow (quarterly, 2025-09-30) — Deferred Tax: 40000.00
GUF.V cash_flow (quarterly, 2025-09-30) — Depreciation: 0.00
GUF.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 0.00
GUF.V income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 0.00
GUF.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 0.00
GUF.V income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 0.00
GUF.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 22015551.00
GUF.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
GUF.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 42054.00
GUF.V income_statement (quarterly, 2025-09-30) — EBIT: 407221.00
GUF.V income_statement (quarterly, 2025-09-30) — EBITDA: 407221.00
GUF.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 126107.00
GUF.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -881677.00
GUF.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 919516.00
GUF.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 56868.00
GUF.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -56868.00
GUF.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 222233.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 126478.00
GUF.V income_statement (quarterly, 2025-09-30) — Gross Profit: 686322.00
GUF.V income_statement (quarterly, 2025-09-30) — Interest Expense: 325167.00
GUF.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 325167.00
GUF.V cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -288853.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 46304842.00
GUF.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -72277.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Investment Properties: 49925000.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 65088.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 65088.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 0.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 24362549.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 24362549.00
GUF.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -211836.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 24236442.00
GUF.V income_statement (quarterly, 2025-09-30) — Net Income: 42054.00
GUF.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 42054.00
GUF.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 42054.00
GUF.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 42054.00
GUF.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 42054.00
GUF.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 42054.00
GUF.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 42054.00
GUF.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -325167.00
GUF.V cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: -72277.00
GUF.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -592824.00
GUF.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -592824.00
GUF.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -325167.00
GUF.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 0.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 21942293.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1822000.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1822000.00
GUF.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 464089.00
GUF.V income_statement (quarterly, 2025-09-30) — Normalized Income: 90391.80
GUF.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 919516.00
GUF.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 56868.00
GUF.V income_statement (quarterly, 2025-09-30) — Operating Income: 464089.00
GUF.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 808238.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 21410685.00
GUF.V income_statement (quarterly, 2025-09-30) — Other Gand A: 222233.00
GUF.V income_statement (quarterly, 2025-09-30) — Other Income Expense: -56868.00
GUF.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 320769.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 58691.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Payables: 2519673.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2519673.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 177943.00
GUF.V income_statement (quarterly, 2025-09-30) — Pretax Income: 82054.00
GUF.V cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
GUF.V cash_flow (quarterly, 2025-09-30) — Purchase Of Investment Properties: -72277.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Receivables: 293686.00
GUF.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 448524.00
GUF.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 0.00
GUF.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -211836.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 11497654.00
GUF.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 222233.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 21410685.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 21942293.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 21942293.00
GUF.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -8530.20
GUF.V income_statement (quarterly, 2025-09-30) — Tax Provision: 40000.00
GUF.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
GUF.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 50646515.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 46304842.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 24362549.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 21942293.00
GUF.V income_statement (quarterly, 2025-09-30) — Total Expenses: 670757.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 28704222.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 50048779.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 26184549.00
GUF.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: -56868.00
GUF.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -56868.00
GUF.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -1921937.00
GUF.V income_statement (annual, 2025-12-31) — +Operating Expense: 1021551.00
GUF.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 274636.00
GUF.V income_statement (annual, 2025-12-31) — +Total Revenue: 4627181.00
GUF.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 1234972.00
GUF.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 2512425.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2512425.00
GUF.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 303187.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 303187.00
GUF.V balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: 0.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: 0.00
GUF.V balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2907617.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2907617.00
GUF.V income_statement (annual, 2025-12-31) — Amortization: 9494.00
GUF.V income_statement (quarterly, 2025-12-31) — Amortization: 0.00
GUF.V income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 9494.00
GUF.V income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 0.00
GUF.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 356810.00
GUF.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 126107.00
GUF.V balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 0.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 0.00
GUF.V balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
GUF.V balance_sheet (annual, 2025-12-31) — Capital Stock: 7537022.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 7537022.00
GUF.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 44168.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 44168.00
GUF.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 44168.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 44168.00
GUF.V cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
GUF.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
GUF.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1688358.00
GUF.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -192744.00
GUF.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -236103.00
GUF.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -161349.00
GUF.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1611819.00
GUF.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 272154.00
GUF.V cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -2494.00
GUF.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -88002.00
GUF.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -274565.00
GUF.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 432.00
GUF.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 159093.00
GUF.V cash_flow (annual, 2025-12-31) — Change In Receivables: -2632.00
GUF.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -9501.00
GUF.V cash_flow (annual, 2025-12-31) — Change In Working Capital: -92696.00
GUF.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -127467.00
GUF.V cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2632.00
GUF.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -9501.00
GUF.V cash_flow (annual, 2025-12-31) — Changes In Cash: -312642.00
GUF.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -81939.00
GUF.V balance_sheet (annual, 2025-12-31) — Common Stock: 7537022.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 7537022.00
GUF.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 21858619.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 21858619.00
GUF.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 1922329.00
GUF.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 548543.00
GUF.V balance_sheet (annual, 2025-12-31) — Current Assets: 366205.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 366205.00
GUF.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 2512425.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2512425.00
GUF.V cash_flow (annual, 2025-12-31) — Deferred Income Tax: 17000.00
GUF.V cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -11000.00
GUF.V cash_flow (annual, 2025-12-31) — Deferred Tax: 17000.00
GUF.V cash_flow (quarterly, 2025-12-31) — Deferred Tax: -11000.00
GUF.V cash_flow (annual, 2025-12-31) — Depreciation: 9494.00
GUF.V cash_flow (quarterly, 2025-12-31) — Depreciation: 0.00
GUF.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 9494.00
GUF.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 0.00
GUF.V income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 9494.00
GUF.V income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 0.00
GUF.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 9494.00
GUF.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 0.00
GUF.V income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 9494.00
GUF.V income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 0.00
GUF.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -364064.00
GUF.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -83674.00
GUF.V income_statement (annual, 2025-12-31) — EBIT: 1032138.00
GUF.V income_statement (quarterly, 2025-12-31) — EBIT: 225414.00
GUF.V income_statement (annual, 2025-12-31) — EBITDA: 1041632.00
GUF.V income_statement (quarterly, 2025-12-31) — EBITDA: 225414.00
GUF.V cash_flow (annual, 2025-12-31) — End Cash Position: 44168.00
GUF.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 44168.00
GUF.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1688358.00
GUF.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -192744.00
GUF.V cash_flow (annual, 2025-12-31) — Free Cash Flow: 1611819.00
GUF.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 272154.00
GUF.V cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 630548.00
GUF.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 164233.00
GUF.V income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -630548.00
GUF.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -164233.00
GUF.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 1012057.00
GUF.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 274636.00
GUF.V balance_sheet (annual, 2025-12-31) — Gross PPE: 0.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 0.00
GUF.V income_statement (annual, 2025-12-31) — Gross Profit: 2704852.00
GUF.V income_statement (quarterly, 2025-12-31) — Gross Profit: 686429.00
GUF.V income_statement (annual, 2025-12-31) — Interest Expense: 1379202.00
GUF.V income_statement (quarterly, 2025-12-31) — Interest Expense: 320088.00
GUF.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1379202.00
GUF.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 320088.00
GUF.V cash_flow (annual, 2025-12-31) — Interest Paid Cff: -1153055.00
GUF.V cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -282745.00
GUF.V balance_sheet (annual, 2025-12-31) — Invested Capital: 46077781.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 46077781.00
GUF.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -236103.00
GUF.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -161349.00
GUF.V balance_sheet (annual, 2025-12-31) — Investment Properties: 49925000.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Investment Properties: 49925000.00
GUF.V balance_sheet (annual, 2025-12-31) — Investments And Advances: 48816.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 48816.00
GUF.V cash_flow (annual, 2025-12-31) — Issuance Of Debt: 307946.00
GUF.V balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
GUF.V balance_sheet (annual, 2025-12-31) — Long Term Debt: 24219162.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 24219162.00
GUF.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 24219162.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 24219162.00
GUF.V cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 307946.00
GUF.V cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -838249.00
GUF.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -217945.00
GUF.V balance_sheet (annual, 2025-12-31) — Net Debt: 24174994.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 24174994.00
GUF.V income_statement (annual, 2025-12-31) — Net Income: -364064.00
GUF.V income_statement (quarterly, 2025-12-31) — Net Income: -83674.00
GUF.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -364064.00
GUF.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -83674.00
GUF.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -364064.00
GUF.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -83674.00
GUF.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -364064.00
GUF.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -83674.00
GUF.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -364064.00
GUF.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -83674.00
GUF.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -364064.00
GUF.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -83674.00
GUF.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -364064.00
GUF.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -83674.00
GUF.V income_statement (annual, 2025-12-31) — Net Interest Income: -1381763.00
GUF.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -322649.00
GUF.V cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: -236103.00
GUF.V cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: -161349.00
GUF.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -530303.00
GUF.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 90001.00
GUF.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -530303.00
GUF.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 90001.00
GUF.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1381763.00
GUF.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -322649.00
GUF.V cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -5000.00
GUF.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
GUF.V balance_sheet (annual, 2025-12-31) — Net PPE: 0.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 0.00
GUF.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 21858619.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 21858619.00
GUF.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1811000.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1811000.00
GUF.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1811000.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1811000.00
GUF.V income_statement (annual, 2025-12-31) — Normalized EBITDA: 1694259.00
GUF.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 411726.00
GUF.V income_statement (annual, 2025-12-31) — Normalized Income: 190668.95
GUF.V income_statement (quarterly, 2025-12-31) — Normalized Income: 80990.75
GUF.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1611819.00
GUF.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 272154.00
GUF.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: 630548.00
GUF.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 164233.00
GUF.V income_statement (annual, 2025-12-31) — Operating Income: 1683301.00
GUF.V income_statement (quarterly, 2025-12-31) — Operating Income: 411793.00
GUF.V income_statement (annual, 2025-12-31) — Operating Revenue: 3257524.00
GUF.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 845323.00
GUF.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 21410685.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 21410685.00
GUF.V income_statement (annual, 2025-12-31) — Other Gand A: 629768.00
GUF.V income_statement (quarterly, 2025-12-31) — Other Gand A: -107653.00
GUF.V income_statement (annual, 2025-12-31) — Other Income Expense: -648602.00
GUF.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -183818.00
GUF.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1411537.00
GUF.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 330062.00
GUF.V balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 61185.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 61185.00
GUF.V income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 4025.00
GUF.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 2494.00
GUF.V balance_sheet (annual, 2025-12-31) — Payables: 2512425.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Payables: 2512425.00
GUF.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2512425.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2512425.00
GUF.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 18850.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 18850.00
GUF.V income_statement (annual, 2025-12-31) — Pretax Income: -347064.00
GUF.V income_statement (quarterly, 2025-12-31) — Pretax Income: -94674.00
GUF.V cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
GUF.V cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
GUF.V balance_sheet (annual, 2025-12-31) — Properties: 0.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
GUF.V cash_flow (annual, 2025-12-31) — Purchase Of Investment Properties: -236103.00
GUF.V cash_flow (quarterly, 2025-12-31) — Purchase Of Investment Properties: -161349.00
GUF.V balance_sheet (annual, 2025-12-31) — Receivables: 303187.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Receivables: 303187.00
GUF.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1922329.00
GUF.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 548543.00
GUF.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 9494.00
GUF.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 0.00
GUF.V income_statement (annual, 2025-12-31) — Rent And Landing Fees: 37329.00
GUF.V income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 37329.00
GUF.V cash_flow (annual, 2025-12-31) — Repayment Of Debt: -838249.00
GUF.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -217945.00
GUF.V balance_sheet (annual, 2025-12-31) — Retained Earnings: 11413980.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 11413980.00
GUF.V income_statement (annual, 2025-12-31) — Salaries And Wages: 344960.00
GUF.V income_statement (annual, 2025-12-31) — Selling General And Administration: 1012057.00
GUF.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 274636.00
GUF.V balance_sheet (annual, 2025-12-31) — Share Issued: 21410685.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 21410685.00
GUF.V income_statement (annual, 2025-12-31) — Special Income Charges: -22079.00
GUF.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 21858619.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 21858619.00
GUF.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 21858619.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 21858619.00
GUF.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -97894.05
GUF.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -21647.25
GUF.V income_statement (annual, 2025-12-31) — Tax Provision: 17000.00
GUF.V income_statement (quarterly, 2025-12-31) — Tax Provision: -11000.00
GUF.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
GUF.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.12
GUF.V balance_sheet (annual, 2025-12-31) — Total Assets: 50401206.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 50401206.00
GUF.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 46077781.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 46077781.00
GUF.V balance_sheet (annual, 2025-12-31) — Total Debt: 24219162.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 24219162.00
GUF.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 21858619.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 21858619.00
GUF.V income_statement (annual, 2025-12-31) — Total Expenses: 2943880.00
GUF.V income_statement (quarterly, 2025-12-31) — Total Expenses: 823179.00
GUF.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 28542587.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 28542587.00
GUF.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 50035001.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 50035001.00
GUF.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 26030162.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 26030162.00
GUF.V income_statement (annual, 2025-12-31) — Total Other Finance Cost: 2561.00
GUF.V income_statement (annual, 2025-12-31) — Total Unusual Items: -652627.00
GUF.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -186312.00
GUF.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -652627.00
GUF.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -186312.00
GUF.V balance_sheet (annual, 2025-12-31) — Working Capital: -2146220.00
GUF.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -2146220.00
GUF.V income_statement (annual, 2025-12-31) — Write Off: 22079.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — +Operating Expense: 1611058000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — +Total Revenue: 7130224000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 1409512000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 1515529000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -638975000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -44395000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1174000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 75000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 96944506.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Basic EPS: 9.89
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 62013000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 555104000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -874531000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 31453000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 96945000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 116081000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 116081000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -9211000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 116081000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -211623000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Change In Payable: 336351000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -231931000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -107203000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 54067000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Common Stock: 96945000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -9211000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 2691180000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 408742000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 4228168000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Current Assets: 3207540000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 28165000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Current Debt: 132642000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 160807000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 6748000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 1864016000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 48715000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Deferred Tax: 309982000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Depreciation: 188116000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 189290000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 189289000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 189289000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 96944506.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Diluted EPS: 9.89
GUFICBIO.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 958401000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 967000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 5000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — EBIT: 1308447000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — EBITDA: 1497737000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — End Cash Position: 116080000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -62437000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 504627000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 187864000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -5000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -684000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 164256000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Goodwill: 0.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 6102000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 1559924000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 2193285000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Gross Profit: 2902056000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Interest Expense: 40064000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 40064000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Interest Income: 18792000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 18792000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -48090000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 5690000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Inventory: 1155669000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 3303601000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -945891000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 75000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 119709000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 63050000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 3288000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 479779000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 483067000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 119709000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 123886000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1182046000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Net Debt: 496340000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Net Income: 958401000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 958401000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 958401000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 958401000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 958401000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 958401000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 958401000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Net Interest Income: -34866000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 0.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 58934000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 119709000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -34866000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -2200000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -77739000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Net PPE: 1554310000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -873847000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -60775000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 2685078000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 49975000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 0.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 1895000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 443583000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 1497053000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Normalized Income: 957884163.77
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 1062395000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Operating Income: 1290998000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Operating Revenue: 7130224000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 96944506.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 40000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 123866000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 2594235000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 6102000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 1000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 43188000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 1000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: -1000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 4627000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 882396000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 176918000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Properties: 47393000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 3826000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 149631000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Other Special Charges: -684000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Payables: 1587397000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 266764000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Pretax Income: 1268383000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: 0.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -874531000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 446525000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 4228168000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 189290000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 23910000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 23910000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -60775000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Research And Development: 44286000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 149631000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1885549000.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 684000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 33441000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 197697000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Share Issued: 96944506.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -60775000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Special Income Charges: 684000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 2691180000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 2685078000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 167163.77
GUFICBIO.NS income_statement (annual, 2022-03-31) — Tax Provision: 309982000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.24
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 0.00
GUFICBIO.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -330572000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Total Assets: 5214018000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 3170959000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Total Debt: 643874000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 2691180000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Total Expenses: 5839226000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 2522838000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 2006478000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 658822000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 13594000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 6748000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 684000.00
GUFICBIO.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 684000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Work In Process: 204516000.00
GUFICBIO.NS balance_sheet (annual, 2022-03-31) — Working Capital: 1343524000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 2235198000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 6797546000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1302646000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 2054657000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -859030000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -43794000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 2498000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 7843000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 96944506.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Basic EPS: 8.22
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 116080000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 913931000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1876007000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 227857000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 96945000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 286019000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 286019000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -10437000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 286019000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -678907000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Change In Payable: -120463000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -553160000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1352530000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 169939000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 96945000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3478082000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 1695886000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 3409039000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 4641086000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 65758000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1207278000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1273036000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 31241000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2882075000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 42412000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Deferred Tax: 270161000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Depreciation: 220313000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 222811000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 222810000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 222810000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 96944506.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Diluted EPS: 8.22
GUFICBIO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 797048000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 225000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 5000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — EBIT: 1133566000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — EBITDA: 1356377000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 286019000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2343076000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 468436000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -2141879000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -5000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -303000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 149007000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Goodwill: 0.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 6788000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 2098451000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 4143818000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Gross Profit: 3388507000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Interest Expense: 66357000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 66357000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Interest Income: 14120000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 14120000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -79058000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 9861000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Inventory: 1834575000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 6592153000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1907265000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 7843000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2500924000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 162099000.00